Medical Global Academy

Program overview

MGA Medical Global Academy’s advanced Fellowship in Movement Disorders is tailored for healthcare professionals looking to deepen their understanding and expertise in the diagnosis, treatment, and ongoing management of movement disorders. This extensive Fellowship offers detailed instruction in Parkinson’s disease, dystonia, tremors, chorea, ataxia, myoclonus, tic disorders and other complicated neurological movement disorders. The program combines theory with clinical practice, providing in-depth theoretical instruction and hands-on experience in neurological assessment, differential diagnosis, therapeutic strategies, and multi-disciplinary patient care. The fellowship focuses on the following primary areas: neuroanatomy and motor control, Parkinsonian syndromes, hyperkinetic and hypokinetic movement disorders, neuroimaging, electrophysiology, neurogenetics, advanced therapeutics, deep brain stimulation (DBS), focused ultrasound therapy and emerging neurorestorative technologies. Participants get to see patients, discuss cases, perform gait and balance assessment, attend multi-disciplinary team meetings and see cutting edge movement disorder clinics.

Skills You Will Gain

  • Detailed knowledge about the neuroanatomical, neurophysiological and motor control mechanisms underlying movement disorders.

  • Knowledge of differentiating Parkinson’s disease, atypical Parkinsonian disorders, dystonia, tremor, chorea, ataxia, myoclonus and tic disorders.

  • Knowledge and skill in neurological examination procedures and movement disorder assessment scales.

  • Understanding of neuroimaging studies, such as MRI, PET, and SPECT and DaTSCAN, for assessment of movement disorder.

  • Knowledge of movement disorders, particularly in relation to their evidence-based pharmacological treatment.

  • Knowledge of how to evaluate patients for Deep Brain Stimulation (DBS) or other advanced neuromodulation therapies.

  • Knowledge of gait analysis, balance evaluation, fall prevention measures and planning rehabilitation.

  • Understand and be familiar with pediatric movement and genetic syndromes and neurogenetic testing approaches.

  • Awareness of psychiatric symptoms, cognitive dysfunction, autonomic dysfunction and sleep disorders related to movement disorders.

  • Knowledge of wearable technologies, remote monitoring, tele-neurology and digital health resources.

  • Skill in handling metabolic, autoimmune, paraneoplastic and systemic movement disorders.

  • Research skills, clinical audit, counselling skills, multidisciplinary working and evidence based decision making skills.

  • Awareness of novel treatments such as gene therapy, focused ultrasound, precision medicine and neurorestorative therapies.

Career Outcomes After the Fellowship

  • Gain in-depth knowledge of the evaluation and treatment of complicated movement disorders.

  • Work in special movement disorder clinics, neurology departments, academic medical centers and multidisciplinary neuroscience institutes.

  • Assist in providing complete care to patients with Parkinson’s disease, dystonia, tremors, ataxia, chorea and other neurological issues.

  • Promote individualized treatment plans and evidence-based neurological care to improve patient outcomes.

  • Increase career opportunities in the areas of neurogenetics, neurorehabilitation, geriatric neurology, and precision medicine.

  • Work with neurology, neurosurgery, physiotherapy, psychology, genetic counselling and rehabilitation.

  • Participate in clinical research, neurodegenerative disease research and innovation in the management of movement disorders.

  • Acquire skills in remotely managing neurological care through tele-neurology, digital health care and wearable monitoring.

  • Establish credibility as a movement disorders/neurodegenerative disease management expert.

  • Teaching, Clinical leadership and Fellowship training roles in Neurology programs.

  • Keep abreast of novel advances in the fields of neurotherapeutics, artificial intelligence, gene therapy and personalized medicine.

  • Enhance healthcare policymaking and patients’ advocacy, and improve neurological service development opportunities.

  • To improve professional development in one of the most dynamic sub-specialty fields of clinical neurology and neurosciences.

What will you learn

Learn from Industry-Leading Movement Disorder Experts 

Skill-Driven Workshops on Diagnosis & Management 

Flexible Learning for Healthcare Professionals 

Future-Ready Movement Disorder Curriculum 

Clinical Training for Real-World Practice 

Course curriculum

  • Overview of movement disorders and their classification
  • Neuroanatomy and neurophysiology of motor control
  • Clinical approach to movement disorders
  • Principles of diagnosis and patient evaluation
  • Pathophysiology and progression of Parkinson’s Disease (PD)
  • Clinical features: motor and non-motor symptoms
  • Atypical Parkinsonian syndromes (MSA, PSP, CBD, DLB)
  • Pharmacological management of PD
  • Non-pharmacological and device-assisted therapies
  • Deep Brain Stimulation (DBS) in Parkinsonism
  • Dystonia: focal, segmental, and generalized
  • Chorea, including Huntington’s Disease
  • Myoclonus and tics
  • Functional (psychogenic) movement disorders
  • Botulinum toxin therapy: techniques and indications
  • Classification and clinical evaluation of tremors
  • Essential tremor vs Parkinsonian tremor
  • Cerebellar ataxias: acquired and genetic
  • Management strategies for tremor and ataxia
  • Surgical options for refractory tremor
  • Common pediatric movement disorders (e.g., Tourette’s, cerebral palsy)
  • Genetic syndromes presenting with movement disorders
  • Diagnostic work-up in pediatric patients
  • Ethical considerations in pediatric care
  • Genetic counseling and testing
  • MRI, SPECT, PET, and DaTSCAN in movement disorders
  • EMG and evoked potentials
  • Role of neurophysiology in diagnosis
  • Interpretation of relevant imaging studies
  • New pharmacological agents in pipeline
  • Gene therapy and neurorestorative strategies
  • Focused Ultrasound Therapy (FUS)
  • Neuromodulation: non-invasive brain stimulation (TMS, tDCS)
  • Artificial intelligence in movement disorder diagnosis
  • Sleep disturbances in Parkinson’s and other disorders
  • REM sleep behavior disorder, restless legs syndrome
  • Autonomic dysfunction: orthostatic hypotension, urinary issues
  • Diagnostic tests: polysomnography, tilt-table testing
  • Management strategies
  •  
  • Cognitive decline and dementia in movement disorders
  • Depression, anxiety, and psychosis in PD
  • Neuropsychological evaluation tools
  • Pharmacologic and behavioral interventions
  • Family and caregiver support strategies
  • Tele-neurology in movement disorder care
  • Remote patient monitoring and wearable devices
  • Digital tools for symptom tracking and virtual assessments
  • Challenges and ethics in digital practice
  • Training patients and caregivers in remote care tools
  • Epidemiology of movement disorders across regions
  • Access to care and disparities in low-resource settings
  • Movement disorder management in diverse healthcare systems
  • Global initiatives and collaborative research
  • Cultural competence in patient care
  • Principles of quality improvement in clinical practice
  • Safety considerations in pharmacological and surgical treatments
  • Monitoring treatment outcomes and adverse events
  • Implementation of clinical protocols and audits
  • Patient feedback and experience measurement
  • Basics of neurogenetics relevant to movement disorders
  • Interpretation of next-generation sequencing (NGS) reports
  • Role of genetic counseling
  • Genotype-phenotype correlations
  • Emerging role of precision medicine in treatment planning
  •  
  • Wilson’s disease, neuroacanthocytosis, and other metabolic syndromes
  • Autoimmune and paraneoplastic movement disorders
  • Mitochondrial disorders with motor manifestations
  • Screening, diagnosis, and interdisciplinary management
  • Geriatric neurology principles
  • Age-related changes in motor function
  • Polypharmacy and drug safety in elderly populations
  • Cognitive-motor interface in elderly patients
  • Fall risk assessment and prevention
  • Gender differences in disease presentation and progression
  • Management of movement disorders during pregnancy and postpartum
  • Hormonal influences on symptom fluctuation
  • Safety of pharmacological agents in women of reproductive age
  • Designing and participating in clinical trials
  • Phases of drug and device development
  • Understanding Good Clinical Practice (GCP) guidelines
  • Ethical and regulatory considerations
  • Working with regulatory bodies and institutional ethics committees
  • Role of physicians in policy development
  • Advocating for patients with chronic neurological conditions
  • Disability rights and access to care
  • Building and supporting patient advocacy groups
  • Legal protections and resources for patients and caregivers
Scroll to Top
Consult Now